Alternative performance measures

In this report, Corbion has included certain non-IFRS financial information. This information is presented to assist in making appropriate comparisons with prior periods, and Corbion uses these measures to assess the operating performance of the business, include them in bonus targets and believes that the information is useful to users of the financial information. The non-IFRS financial measures do not have a standardized meaning prescribed by the IASB, and therefore may not be comparable to similar measures presented by other issuers.

Corbion believes the APMs are relevant based on the following considerations.

APM category

Relevance

EBITDA

Corbion believes the measure provides valuable insight in the understanding of operating profitability and the cash flow component thereof. Further, it is a common APM used by other companies, therefore providing better comparability of Corbion's performance to other companies. This APM is also relevant for bonus targets (IAS 19/ IFRS 2), segment information (IFRS 8) and impairment testing (IAS 36).

Adjustments, Adjusted EBITDA, Adjusted operating result, Adjusted result after taxes, Adjusted EBITDA margin%

Adjustments and the related adjusted APMs show items that in view of management require disclosure to assist in making appropriate comparisons with prior periods and to assess the underlying operating performance of the business as it excludes sizeable items of an incidental/one-off nature. This APM is also relevant for bonus targets (IAS 19/ IFRS 2), segment information (IFRS 8) and impairment testing (IAS 36).

Organic EBITDA growth, Organic sales growth, Organic operating profit growth, Adjusted EBITDA excluding acquisitions and divestments, at constant currencies

The organic growth measures are used to explain the underlying result development of the business by separate disclosing, and thus excluding, the impacts from currencies and acquisitions and divestments. It thus provides a better basis for comparison and assessment of business performance without distortion from these external sources.

Covenant EBITDA, Interest cover, Covenant net debt position, Total net debt position

Corbion believes these measures are important as the existing debt providers to the company (RCF and USPP lenders) require these measures to be used in the external loan documentation.

ROCE, Capital employed, Average capital employed

ROCE and the related APMs are relevant measures analyzing profitability and for comparing profitability levels across companies in terms of capital sizes and returns therefrom. Further, these are widely used APM’s by other companies, and therefore are providing better comparability of Corbion’s performance to other companies. This APM is also relevant for bonus targets (IAS 19/ IFRS2).

Free cash flow

This measure provides insight into the cash flows available for debt reduction and dividend payments. Free cash flow should not be read as an alternative to, for example, operating cash flow. This APM is also relevant for bonus targets (IAS 19).

The table below gives an overview of the alternative performance measures used and their definitions.

APM

Definition

EBITDA

The operating result before depreciation, amortization, and (reversal of) impairment of (in)tangible fixed assets.

Adjusted EBITDA

EBITDA as defined above after applying adjustments.

Adjusted EBITDA margin %

Adjusted EBITDA as defined above divided by net sales x 100.

Adjusted EBITDA excluding acquisitions and divestments, at constant currencies

Adjusted EBITDA as defined above excluding the impact of acquisitions and divestments, based on prior-year currency rates.

Covenant EBITDA

Adjusted EBITDA as defined above increased by cash dividend of joint ventures received and annualization effect of newly acquired and/or divested subsidiaries.

Organic EBITDA growth

Adjusted EBITDA as defined above versus prior year excluding impact of acquisitions and divestments and excluding currency impact.

Organic sales growth

Sales versus prior year excluding impact of acquisitions and divestments and excluding currency impact.

Adjusted operating result

Operating result after adjustments.

Adjusted result after taxes

Result after taxes after adjustments.

Interest cover

Covenant EBITDA as defined above divided by net interest income and charges.

Covenant net debt position

Borrowings (excluding subordinated loans) and lease liabilities less cash and cash equivalents, including third-party guarantees which are required to be included under the debt covenants.

Total net debt position

Borrowings and lease liabilities less cash and cash equivalents, including third-party guarantees which are required to be included under the debt covenants.

Capital employed

The sum of equity, borrowings, lease liabilities, and other non-current liabilities minus cash and cash equivalents.

Average capital employed

Average of the quarterly average capital employed in the reporting period.

Free cash flow

Cash flow from operating activities plus cash flow from investment activities.

Return on capital employed (ROCE)

Adjusted operating profit as defined above, including adjusted operating profit from joint ventures and associates, divided by the average capital employed x 100.

Adjustments

Adjustments relate to significant items in the income statement of such size, nature, or incidence that in view of management require disclosure to assist in making appropriate comparisons with prior periods and to assess the operating performance of the business. These items include amongst others write-down of inventories to net realizable value, reversals of write-downs, impairments, reversals of impairments, additions to and releases from provisions for restructuring and reorganization, results on assets sold, gains on the sale of subsidiaries, joint ventures and associates, and any other provision being formed or released. Restructuring costs are defined as the estimated costs of initiated reorganizations, which have been approved by the Executive Committee, and which generally involve the realignment of certain parts of the organization. The company only adjusts for items when the aggregate amount of the events per line item of the income statement exceeds a yearly threshold of € 0.5 million as well as adjustments, each above € 0.1 million, in relation to previously recognized adjustments.

The table below gives a selection of the APMs used versus the most directly comparable IFRS measure.

€ million

2025

2024

The following APMs have been reported based on continued operations

Operating result

116.5

77.3

Depreciation, amortization, and impairments

88.0

87.0

EBITDA

204.5

164.3

Adjustments to EBITDA

- Litigation settlements

-3.8

0.6

- Restructuring costs

3.6

9.4

- Inefficiencies at start-up at our new lactic acid facility in Thailand

-

1.0

- Remeasurement contingent purchase price SB Renewable Oils

-

-0.8

- Planned settlement of defined benefit schemes

-

0.5

Total adjustments to EBITDA

-0.2

10.7

Adjusted EBITDA

204.3

175.0

Adjusted EBITDA (A)

204.3

175.0

Net sales (B)

1,267.4

1,288.1

Adjusted EBITDA margin (A/B)

16.1%

13.6%

Operating result

116.5

77.3

Adjustments to operating result

- Adjustments to EBITDA

-0.2

10.7

- (Reversal of) impairments and incidental accelerated depreciation

2.2

2.7

Total adjustments to operating result

2.0

13.4

Adjusted operating result

118.5

90.7

Result after taxes

74.8

45.9

Adjustments to result after taxes

- Total adjustments to operating result

2.0

13.4

- Tax effects on adjustments

-0.4

-2.9

Total adjustments to result after taxes

1.6

10.5

Adjusted result after taxes

76.4

56.4

Adjusted EBITDA

204.3

175.0

Impact acquisitions and divestments

4.5

-4.5

Currency impact

13.0

2.4

Adjusted EBITDA excluding acquisitions and divestments, at constant currencies

221.8

172.9

Adjusted EBITDA prior year (A)

175.0

140.2

Adjusted EBITDA excluding acquisitions and divestments, at constant currencies current year (B)

221.8

172.9

Organic adjusted EBITDA growth ((B-A)/A)*100%

26.7%

23.3%

Sales

1,267.4

1,288.1

Impact acquisitions and divestments

4.5

-4.5

Currency impact

44.4

8.5

Sales excluding acquisitions and divestments, at constant currencies

1,316.3

1,292.1

Sales prior year (A)

1,288.1

1,264.1

Sales excluding acquisitions and divestments, at constant currencies current year (B)

1,316.3

1,292.1

Organic Sales growth ((B-A)/A)*100%

2.2%

2.2%

Operating profit

116.5

77.3

Impact acquisitions and divestments

4.5

-4.5

Currency impact

7.4

1.1

Operating profit excluding acquisitions and divestments, at constant currencies

128.4

73.9

Operating profit prior year (A)

77.3

77.3

Operating profit excluding acquisitions and divestments, at constant currencies current year (B)

128.4

73.9

Organic Operating profit growth ((B-A)/A)*100%

66.1%

-4.4%

The following APMs have been reported based on total operations

Cash flow from operating activities

160.9

184.1

Cash flow from investment activities

-70.1

166.0

Free cash flow

90.8

350.1

Equity

742.6

772.5

Borrowings

399.7

450.2

Lease liabilities

46.9

59.0

Other non-current liabilities

1.4

3.9

-/- Cash and cash equivalents

-44.7

-49.3

Capital employed 31/12

1,145.9

1,236.3

Capital employed end Q4 prior year (A)

1,236.3

1,364.8

Capital employed end Q1 (B)

1,237.6

1,399.2

Capital employed end Q2 (C)

1,182.0

1,224.2

Capital employed end Q3 (D)

1,198.1

1,242.2

Capital employed end Q4 current year (E)

1,145.9

1,236.3

Average capital employed for the year ((A+B)/2+(B+C)/2+(C+D)/2+(D+E)/2)/4)

1,202.2

1,291.5

Adjusted operating result

118.5

102.7

Adjusted operating result from joint ventures and associates

1.0

1.6

Adjusted operating result basis for ROCE (A)

119.5

104.3

Average capital employed for the year (B)

1,202.2

1,291.5

Return on capital employed (A/B)

9.9%

8.1%

Borrowings

399.7

450.2

Lease liabilities

46.9

59.0

-/- Cash and cash equivalents

-44.7

-49.3

Total net debt position

401.9

459.9

Borrowings

399.7

450.2

Lease liabilities

46.9

59.0

-/- Subordinated loan

-99.8

-99.7

-/- Cash and cash equivalents

-44.7

-49.3

Covenant net debt position

302.1

360.2

Adjusted EBITDA including discontinued operations

204.3

187.7

Impact sold business

-

-12.7

Cash dividend of joint ventures and associates

-

-

Covenant EBITDA

204.3

175.0

Covenant net debt position (A)

302.1

360.2

Covenant EBITDA (B)

204.3

175.0

Covenant net debt position/covenant EBITDA (A/B)

1.5

2.1

Interest income (Note 7 consolidated financial statements)

-4.6

-5.8

Interest expenses (Note 7 consolidated financial statements)

13.1

18.9

Interest expense on lease liabilities (Note 7 consolidated financial statements)

2.1

2.4

Net interest financial income and charges

10.6

15.5

Covenant EBITDA (A)

204.3

175.0

Net interest financial income and charges (B)

10.6

15.5

Interest cover (A/B)

19.3

11.3

TotalEnergies Corbion B.V.

Adjusted operating result

1.9

3.1

Depreciation, amortization, and impairments

8.3

8.5

EBITDA

10.2

11.6